24 results for “partnership”
Curaleaf Laboratories, one of the UK’s leading manufacturers and distributors of EU-GMP medical cannabis products and Herdade das Barrocas (HDB), a Portuguese cultivator known for its cannabis genetics and cultivation expertise, […]
Curaleaf Laboratories, one of the UK’s leading providers of medicinal cannabis products, is pleased to announce a landmark partnership with Australian Natural Therapeutics Group (ANTG), one of Australia’s most respected producers […]
A new research agreement has been signed between the University of Malta and the Authority for the Responsible Use of Cannabis.
In a landmark new collaboration, the CBD by BRITISH CANNABIS™ range of pharmacy-quality CBD food supplements is set to become available on prescription to pain patients for the first time […]
Dispensary Green is to include complimentary Boveda packs with all medical cannabis flower prescriptions.
Elixinol’s revamped hemp-based cosmetic collection is here to elevate your skincare routine
Towergate Insurance and the Medical Cannabis Clinicians Society (MCCS) have extended their partnership
NaturalWorks entered a co-ordinated partnership, via its primary supplier’s Primary Authority (PA) partnership with Hertfordshire County Council Trading Standards.
A cannabis products firm and the official kit supplier to the US ski team have announced an unlikely partnership.
Ananda Pharma has taken another major step forward in bringing its flagship MRX1 CBD oral solution to market.
Dr Sue Clenton, Medical Director at Releaf Cannabis Clinic, shares her insight from the frontline of an emerging field of medicine.
A new initiative is giving patients a direct voice in how the UK’s medical cannabis market is shaped.
The team at Prohibition Partners shares how they think things will shape up for medical cannabis in 2026.
In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field […]
The company is preparing to reach a major regulatory milestone and bring its lead product to market in early 2026.
The afternoon sessions at Tuesday’s inaugural Cannabis Health Symposium 2025 moved beyond the fundamentals of cannabis medicine and its potential, to the practical realities of prescribing this relatively new medicine in the […]
A quick rundown of the highlights so far, and what’s still left to look forward to.
The event brought together expert medical and scientific voices and powerful patient perspectives.
Healthcare professionals attending the Cannabis Health Symposium next month will be able to earn CPD points to support their professional development. The Cannabis Health Symposium is a Continuing Professional Development […]
Almost seven years since medical cannabis was legalised in the UK on 1st November 2018, less than 1% of the UK’s approximate 100,000 doctors on the General Medical Council (GMC) […]
Curaleaf Laboratories’ sponsorship forms part of its ongoing collaboration with the MCCS.
The international patient-led organisation We, The Patients, will bring its educational series to London next month.
The Medical Cannabis Clinicians Society (MCCS) and Curaleaf Laboratories have formed a new partnership aimed at addressing critical knowledge gaps.
Curaleaf Laboratories, part of Curaleaf International, today announced the UK launch of the Curaleaf Que Medical Inhalation Device (QMID), the first CE-certified liquid inhaler for cannabis-based medicines. Available on prescription, […]
